obesity drug news today glp-1 october 21 2025 Outlook for in 2025: more than a transition year How GLP-1s Are Shaping Beauty
Description
The point is that they appear to be systemic metabolic therapies with effects that reach beyond simple appetite suppression
This is all very hand-wavy theory right now, but could it be the insulin thats having some of these effects in the brain? It is clear that insulin dysregulation affects the brain, as evidenced by certain neurodegenerative diseases
Ozempic (semaglutide) has dominated the GLP-1 market due to its early approval, strong efficacy in glycemic control, and weekly administration convenience
In humans, LPS infusion raises GLP-1 levels in healthy young subjects (9)
Anna Lembke, a Stanford University addiction medicine specialist
Microbial modulation of energy availability in the colon regulates intestinal transit
